 |
|
Letter regarding “Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation”
Yun-Fan Liaw
Clin Mol Hepatol. 2024;30(2):269-271. Published online 2024 Jan 31 DOI: https://doi.org/10.3350/cmh.2024.0064
|
|
Citations to this article as recorded by
 Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring
Ying-Nan Tsai, Jia-Ling Wu, Yao-Chun Hsu
Clinical and Molecular Hepatology.2024; 30(2): 293. CrossRef
|